Jonathan Monson - 16 Feb 2023 Form 4 Insider Report for BOSTON SCIENTIFIC CORP (BSX)

Role
SVP, Global Controller and CAO
Signature
/s/ Susan Thompson, Attorney-in-Fact
Issuer symbol
BSX
Transactions as of
16 Feb 2023
Net transactions value
-$52,609
Form type
4
Filing time
21 Feb 2023, 15:19:56 UTC
Previous filing
16 Feb 2023
Next filing
22 Feb 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BSX Common Stock Options Exercise $0 +990 +3% $0.000000 33,991 16 Feb 2023 Direct F1
transaction BSX Common Stock Tax liability $21,195 -456 -1.3% $46.48 33,535 16 Feb 2023 Direct
transaction BSX Common Stock Options Exercise $0 +1,000 +3% $0.000000 34,535 17 Feb 2023 Direct F1
transaction BSX Common Stock Tax liability $19,593 -421 -1.2% $46.54 34,114 17 Feb 2023 Direct
transaction BSX Common Stock Options Exercise $0 +637 +1.9% $0.000000 34,751 18 Feb 2023 Direct F2
transaction BSX Common Stock Tax liability $11,821 -254 -0.73% $46.54 34,497 18 Feb 2023 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction BSX Restricted Stock Units Options Exercise $0 -990 -25% $0.000000 2,970 16 Feb 2023 Common Stock 990 Direct F1, F3
transaction BSX Restricted Stock Units Options Exercise $0 -1,000 -33% $0.000000 2,000 17 Feb 2023 Common Stock 1,000 Direct F1, F4
transaction BSX Deferred Stock Units Options Exercise $0 -637 -50% $0.000000 638 18 Feb 2023 Common Stock 637 Direct F2, F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit represents the Company's commitment to issue one share of Boston Scientific common stock.
F2 Each deferred stock unit represents the Company's commitment to issue on share of Boston Scientific common stock.
F3 Shares of common stock will be issued to the reporting person in four equal annual installments beginning on February 16, 2023, the first anniversary of the date of grant.
F4 Shares of common stock will be issued to the reporting person in four equal annual installments beginning on February 17, 2022, the first anniversary of the date of grant.
F5 Shares of common stock will be issued to the reporting person in four equal annual installments beginning on February 18, 2021, the first anniversary of the date of grant.